Physicochemical Properties
| Molecular Formula | C10H12N2 |
| Molecular Weight | 160.22 |
| Exact Mass | 160.1 |
| CAS # | 2743-90-0 |
| Related CAS # | (S)-(-)-Anatabine;581-49-7;(R)-(+)-Anatabine;126454-22-6 |
| PubChem CID | 261474 |
| Appearance | Light yellow to yellow liquid(Density:1.045±0.06 g/cm3) |
| Density | 1.0±0.1 g/cm3 |
| Boiling Point | 269.0±28.0 °C at 760 mmHg |
| Flash Point | 116.5±24.0 °C |
| Vapour Pressure | 0.0±0.6 mmHg at 25°C |
| Index of Refraction | 1.547 |
| LogP | 0.89 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 1 |
| Heavy Atom Count | 12 |
| Complexity | 165 |
| Defined Atom Stereocenter Count | 0 |
| SMILES | C1=CCNC(C1)C2=CN=CC=C2 |
| InChi Key | SOPPBXUYQGUQHE-UHFFFAOYSA-N |
| InChi Code | InChI=1S/C10H12N2/c1-2-7-12-10(5-1)9-4-3-6-11-8-9/h1-4,6,8,10,12H,5,7H2 |
| Chemical Name | 3-(1,2,3,6-tetrahydropyridin-2-yl)pyridine |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| References | [1]. Lai FY, et al. Levels of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in raw wastewater as an innovative perspective for investigating population-wide exposure to third-hand smoke. Sci Rep. 2018 Sep 5;8(1):13254. |
| Additional Infomation |
1,2,3,6-Tetrahydro-2,3'-bipyridine has been reported in Nicotiana tabacum and Nicotiana with data available. See also: Anatabine (annotation moved to). |
Solubility Data
| Solubility (In Vitro) | DMSO: 125 mg/mL (780.18 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.08 mg/mL (12.98 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.08 mg/mL (12.98 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. Solubility in Formulation 3: ≥ 2.08 mg/mL (12.98 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 6.2414 mL | 31.2071 mL | 62.4142 mL | |
| 5 mM | 1.2483 mL | 6.2414 mL | 12.4828 mL | |
| 10 mM | 0.6241 mL | 3.1207 mL | 6.2414 mL |